1053 / 1241
Modified RECIST: HCC
CR
PR
SD
PD
Resolution of
arterially enhancing
target lesions
At least 30%
reduction in sum
longest diameter of
arterially enhancing
target lesions
Response not
fulfilling PR or PD
category
At least 20%
increase in sum
longest diameter of
arterially enhancing
target lesions or
new lesions
Lesions measured in the arterial phase: Max 2 lesions
Modified RECIST Criteria:
Hepatocellular Carcinoma
Edeline et al. Cancer 2012;118:147-56